Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

819 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Not Yet Recruiting

A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial Cancers

NCT07545122

Conditions
Breast Diseases, Breast Neoplasms, Colonic Diseases, +16 more
Locations
  • Tasman Oncology Research Gold Coast, Queensland, Australia
  • Calvary Mater Hospital Newcastle Newcastle, Queensland, Australia
  • Linear Clinical Research Perth, Western Australia, Australia
View Trial Details
Not Yet Recruiting

Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer

NCT07552181

Conditions
Breast Diseases, Breast Neoplasms, Early Stage Triple-Negative Breast Carcinoma, +7 more
Locations
  • Cedars-Sinai Medical Center Beverly Hills Beverly Hills, California, United States
  • CS Cancer at Valley Oncology Medical Group Tarzana, California, United States
  • Hunt Cancer Institute, an Affiliate of CS Cancer Torrance, California, United States
View Trial Details

Related conditions